Hepatitis C virus research
Hepatitis C virus research is a research topic within Hepatology. Science Explorer counts 58k research works in it since 1950. 15.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the epidemiology, treatment, and outcomes of hepatitis C virus infection. It covers topics such as antiviral therapy, genetic variation in viral clearance, global epidemiology, liver-related mortality, immune responses, and the impact of comorbidities like HIV and diabetes.
- Hepatitis C Virus
- Treatment
- Ribavirin
- Interferon
- Viral Clearance
- Genetic Variation
- Epidemiology
- Liver Disease
- Immune Response
- Antiviral Therapy
- Research works
- 58k fractional, since 1950
- In the world top 10%
- 9.1k per year above
- Top-10% rate
- 15.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -10% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Hepatitis C virus research research?
By volume, the United States and China publish the most (1.4k and 1.1k works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.4k works
- 2 China 1.1k works
- 3 India 418 works
- 4 United Kingdom 270 works
- 5 Egypt 264 works
- 6 Italy 249 works
- 7 Japan 242 works
- 8 Pakistan 230 works
- 9 France 198 works
- 10 Spain 193 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Hepatitis C virus research research?
By volume in 2022–2025, Ain Shams University publishes the most Hepatitis C virus research research, followed by University of North Carolina at Chapel Hill and UNSW Sydney.
By volume, 2022–2025
- 1 Ain Shams University Egypt 38 works
- 2 University of North Carolina at Chapel Hill United States 36 works
- 3 UNSW Sydney Australia 28 works
- 4 Cairo University Egypt 28 works
- 5 Peking University China 24 works
- 6 Capital Medical University China 23 works
- 7 Johns Hopkins University United States 23 works
- 8 Sun Yat-sen University China 22 works
- 9 Inserm France 20 works
- 10 University of California, San Francisco United States 18 works
Who are the leading researchers in Hepatitis C virus research?
The most-cited researchers publishing on Hepatitis C virus research include Roger Chou, Reza Malekzadeh and Louisa Degenhardt.
- 1 Roger Chou 14k citations
- 2 Reza Malekzadeh 6.7k citations
- 3 Louisa Degenhardt 5.7k citations
- 4 Ziad A. Memish 5.3k citations
- 5 Joshua A. Salomon 5.1k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Hepatitis C virus research research done?
The largest centres of Hepatitis C virus research research in 2022–2025 are Beijing (China), London (United Kingdom), Guangzhou (China) and Paris (France). Among places with at least 20 works in it, it is an unusually large share of all research in Kaohsiung City.
Largest cities, 2022–2025
Where it is the local speciality
- Kaohsiung CityTW · 33.7 works8.2×
Location quotient: how much more of its research is in Hepatitis C virus research than the world average.
Where is the best place to study Hepatitis C virus research?
Among universities, judged by research, UNSW Sydney, Menoufia University and Medizinische Hochschule Hannover score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | UNSW Sydney Australia | 55.8 | 19.0% | 4.9× | 28 | +41.4% |
| 2 | Menoufia University Egypt | 55.0 | 2.3% | 10.2× | 16 | +221.4% |
| 3 | Medizinische Hochschule Hannover Germany | 54.2 | 18.6% | 10.6× | 16 | -30.0% |
| 4 | Chinese University of Hong Kong Hong Kong | 52.1 | 26.4% | 3.4× | 16 | -5.5% |
| 5 | University of Hong Kong Hong Kong | 49.5 | 33.3% | 1.8× | 11 | -3.2% |
| 6 | Ain Shams University Egypt | 49.1 | 1.9% | 7.6× | 38 | +75.3% |
| 7 | Stanford University United States | 47.4 | 30.4% | 1.9× | 16 | +35.2% |
| 8 | Kaohsiung Medical University Taiwan | 47.4 | 15.6% | 12.7× | 8 | +22.8% |
| 9 | Capital Medical University China | 45.5 | 16.3% | 5.8× | 23 | -7.3% |
| 10 | Chang Gung University Taiwan | 44.6 | 7.2% | 14.5× | 14 | -2.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Hepatitis C virus research research growing?
Output in 2018–2022 was 10% lower than in 2013–2017, peaking in 2015. The fastest-growing topics are Hepatitis C virus research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.